GitLab Inc. (GTLB) shares experienced a significant surge in today’s pre-market trading, fueled by the company’s impressive second-quarter financial results and optimistic FY25 guidance. The company reported earnings of 15 cents per share, exceeding analyst expectations by 50%. Revenue for the quarter reached $182.6 million, surpassing the consensus estimate of $176.889 million by 3.23%. This positive news propelled GitLab shares upward by 16.8% to $52.21 in pre-market trading.
Here’s a rundown of other notable movers in today’s pre-market session:
Gainers:
*
WiSA Technologies, Inc. (WISA):
The company’s stock jumped 63.2% to $2.22 after announcing a definitive asset purchase agreement to acquire the Datavault® intellectual property and IT assets from privately held Data Vault Holdings Inc.*
Conifer Holdings, Inc. (CNFR):
Shares rose 39.1% to $1.60 following the company’s announcement of the completed sale of its insurance agency operations for a $45 million consideration. Brian Roney was appointed as the new CEO.*
LogicMark, Inc. (LGMK):
The stock gained 29.4% to $0.2618, building on a strong performance on Monday.*
Atara Biotherapeutics, Inc. (ATRA):
Shares climbed 17.2% to $7.99 after the company announced a $36 million registered direct offering of 758,900 shares at $8.25 per share.*
Tantech Holdings Ltd (TANH):
The stock gained 16% to $0.1613 in pre-market trading.*
BTCS Inc. (BTCS):
Shares rose 10% to $1.10, recovering from a decline on Tuesday.*
Genelux Corporation (GNLX):
The stock climbed 9.1% to $2.27, rebounding from a loss on Tuesday.*
Clover Health Investments, Corp. (CLOV):
Shares gained 8.4% to $2.71 after subsidiary Iowa Clinic signed a multi-year agreement with Counterpart Health to deploy AI technology across Midwest providers.*
Astera Labs, Inc. (ALAB):
The stock increased 4% to $40.66, partially recovering from Tuesday’s decline.Losers:
*
Athira Pharma, Inc. (ATHA):
The company’s stock plummeted 72.7% to $0.7739 after announcing that its Phase 2/3 LIFT-AD clinical trial for Fosgonimeton in mild-to-moderate Alzheimer’s disease failed to meet its primary or key secondary endpoints.*
Oragenics, Inc. (OGEN):
Shares fell 32.2% to $0.7254, extending a decline from Tuesday. The company recently announced the completion of filing for its ONP-002 drug in preparation for a Phase IIa clinical trial in concussed patients.*
Focus Universal Inc. (FCUV):
The stock dropped 16.4% to $0.2530, reversing gains from Tuesday.*
Shuttle Pharmaceuticals Holdings, Inc. (SHPH):
Shares declined 16.2% to $1.76. The company was granted a patent for selective histone deacetylase inhibitors.*
Zscaler, Inc. (ZS):
The stock fell 15.2% to $163.70 following the release of fourth-quarter earnings.*
Asana, Inc. (ASAN):
Shares declined 14.6% to $11.35 despite reporting upbeat second-quarter results, as the company issued weak guidance for the third quarter.*
PagerDuty, Inc. (PD):
The stock dropped 14.4% to $15.66. PagerDuty reported better-than-expected earnings for its second quarter, but sales fell short of estimates.*
Elevai Labs Inc. (ELAB):
Shares declined 11.3% to $0.2839, erasing gains from Tuesday. The company’s subsidiary, Elevai Skincare, announced data results demonstrating the potential of its Elevai Exosomes in hair restoration.*
Motorsport Games Inc. (MSGM):
The stock dipped 11.3% to $1.16, following gains on Tuesday.*
